Ipamorelin – CJC-1295 (No DAC) 10MG

Description

CAS Numbers:
Ipamorelin: 170851-70-4
CJC-1295 (No DAC / Mod GRF 1-29): 863288-34-0

Disclaimer:
For research use only. Not for human consumption. Intended for laboratory-based studies by qualified professionals. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease.

Overview

Ipamorelin + CJC-1295 (No DAC) is a research peptide combination commonly studied for its role in pulsatile growth hormone signaling and hypothalamic-pituitary pathway modulation. Ipamorelin is a selective ghrelin receptor agonist investigated for its interaction with growth hormone secretagogue receptors (GHSR), while CJC-1295 (No DAC), also known as Mod GRF 1-29, is a modified GHRH analog studied for its ability to support endogenous growth hormone pulse signaling.

This peptide pairing is widely utilized in experimental models exploring endocrine regulation, recovery pathways, metabolic signaling, tissue repair mechanisms, sleep-associated hormonal activity, and cellular recovery processes. Due to the short-acting nature of CJC-1295 without DAC, the combination is frequently researched for its ability to mimic more physiologic pulsatile GH release patterns.

Specifications

Form: Lyophilized powder
Blend: Ipamorelin + CJC-1295 (No DAC)
Quantity: 10MG total per vial
Grade: Research Use Only
Storage: Store in a cool, dry environment away from direct light